Sweden
GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.
Drugs known as GLP-1 agonists or G... [1543 chars]
Related
Share this page
Guest Posts by Easy Branches